Skip to content

Nasdaq · CIK 0001831868

ICU SeaStar Medical Holding Corp

Insider trading from SEC Form 4. Last filing Feb 10, 2026. Close $3.61 on Oct 9, 2026, +63% from the 52-week low and -43% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

ICUOct 9, 2026 · close 3.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at SeaStar Medical Holding Corp, scored.

ScoreInsiderValueHoldingsPrice contextFiled
44ModerateJennifer A Baird
director
buy
$987
4,200 shares
+13%0% from low-90% from high
48ModerateMichael Messinger
Chief Financial Officer
buy
$5,098
14,500 shares
+483%+17% from low-85% from high
46ModerateKenneth Van Heel
director
buy
$31k
35,000 shares
+243%+171% from low-83% from high
37WeakKevin Chung
Chief Medical Officer
buy
$8,000
10,000 shares
+21%+141% from low-85% from high
46ModerateJennifer A Baird
director
buy
$4,174
10,000 shares
+56%+28% from low-92% from high
51ModerateJohn Neuman
director
buy
$14k
40,000 shares
+100%+8% from low-93% from high
49ModerateJennifer A Baird
director
buy
$13k
10,000 shares
-+6% from low-75% from high
47ModerateKevin Chung
Chief Medical Officer
buy
$5,625
4,500 shares
+33%+6% from low-75% from high
21WeakKevin Chung
Chief Medical Officer
buy
$8,458
4,250 shares
+45%-

Transactions

The last 43 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Feb 6, 2026Kevin Chung
Chief Medical Officer
AGrant or award
Common Stock, par value $0.0001
+15,000$0.00$020,819Feb 10, 2026
Feb 6, 2026Jennifer A Baird
director
AGrant or award
Common Stock, par value $0.0001
+3,000$0.00$06,620Feb 10, 2026
Feb 6, 2026Kenneth Van Heel
director
AGrant or award
Common Stock, par value $0.0001
+3,000$0.00$07,940Feb 10, 2026
Feb 6, 2026Bernadette N Vincent
director
AGrant or award
Common Stock, par value $0.0001
+3,000$0.00$04,200Feb 10, 2026
Feb 6, 2026Bradford K Towne
Principal Accounting Officer
AGrant or award
Common Stock, par value $0.0001
+7,500$0.00$09,050Feb 10, 2026
Feb 6, 2026Eric Schlorff
Chief Executive Officer
AGrant or award
Common Stock, par value $0.0001
+30,000$0.00$039,852Feb 10, 2026
Feb 6, 2026John Neuman
director
AGrant or award
Common Stock, par value $0.0001
+3,000$0.00$012,200Feb 10, 2026
Dec 19, 2025Jennifer A Baird
director
POpen-market purchase
Common Stock
+4,200$0.24$98736,200Dec 22, 2025
Dec 9, 2025Michael Messinger
Chief Financial Officer
POpen-market purchase
Common Stock
+14,500$0.35$5,09817,500Dec 11, 2025
Aug 26, 2025Kenneth Van Heel
director
POpen-market purchase
Common Stock, par value $0.0001 per share
+25,000$0.89$22k39,400Aug 28, 2025
Aug 27, 2025Kenneth Van Heel
director
POpen-market purchase
Common Stock, par value $0.0001 per share
+10,000$0.86$8,56549,400Aug 28, 2025
Aug 22, 2025Kevin Chung
Chief Medical Officer
POpen-market purchase
Common Stock, par value $0.0001 per share
+10,000$0.80$8,00058,184Aug 25, 2025
Jul 10, 2025Jennifer A Baird
director
AGrant or award
Common Stock, par value $0.0001 per share
+4,000$0.00$032,000Jul 16, 2025
Jun 4, 2025Bernadette N Vincent
director
MOption exercise
Common Stock, par value $0.0001 per share
+2,667$0.00$08,000Jul 16, 2025
Jun 4, 2025Kenneth Van Heel
director
MOption exercise
Common Stock, par value $0.0001 per share
+4,000$0.00$010,400Jul 16, 2025
Jun 4, 2025John Neuman
director
MOption exercise
Common Stock, par value $0.0001 per share
+2,667$0.00$088,000Jul 16, 2025
Jul 10, 2025Bernadette N Vincent
director
AGrant or award
Common Stock, par value $0.0001 per share
+4,000$0.00$012,000Jul 16, 2025
Jul 10, 2025Kenneth Van Heel
director
AGrant or award
Common Stock, par value $0.0001 per share
+4,000$0.00$014,400Jul 16, 2025
Jul 10, 2025John Neuman
director
AGrant or award
Common Stock, par value $0.0001 per share
+4,000$0.00$092,000Jul 16, 2025
Jun 4, 2025John Neuman
director
MOption exercise
Restricted Stock Unitderivative
-2,667$0.00$00Jul 16, 2025
Jun 4, 2025Kenneth Van Heel
director
MOption exercise
Restricted Stock Unitderivative
-4,000$0.00$00Jul 16, 2025
Jun 4, 2025Bernadette N Vincent
director
MOption exercise
Restricted Stock Unitderivative
-2,667$0.00$00Jul 16, 2025
Jul 1, 2025Eric Schlorff
Chief Executive Officer
MOption exercise
Common Stock, par value $0.0001 per share
+21,667$0.00$098,517Jul 3, 2025
Jul 1, 2025Kevin Chung
Chief Medical Officer
MOption exercise
Common Stock, par value $0.0001 per share
+5,000$0.00$048,184Jul 3, 2025
Jul 1, 2025Kevin Chung
Chief Medical Officer
MOption exercise
Restricted Stock Unitderivative
-5,000$0.00$00Jul 3, 2025
Jul 1, 2025Eric Schlorff
Chief Executive Officer
MOption exercise
Restricted Stock Unitderivative
-21,667$0.00$00Jul 3, 2025
Jun 4, 2025Jennifer A Baird
director
MOption exercise
Common Stock, par value $0.0001 per share
+2,667$0.00$018,000Jul 2, 2025
Jun 30, 2025Jennifer A Baird
director
POpen-market purchase
Common Stock, par value $0.0001 per share
+10,000$0.42$4,17428,000Jul 2, 2025
Jun 4, 2025Jennifer A Baird
director
MOption exercise
Restricted Stock Unitderivative
-2,667$0.00$00Jul 2, 2025
Jun 24, 2025John Neuman
director
POpen-market purchase
Common Stock, par value $0.0001 per share
+40,000$0.36$14k80,000Jun 27, 2025
May 20, 2025Jennifer A Baird
director
POpen-market purchase
Common Stock, par value $0.0001 per share
+10,000$1.28$13k10,000May 22, 2025
May 20, 2025Kevin Chung
Chief Medical Officer
POpen-market purchase
Common Stock, par value $0.0001 per share
+4,500$1.25$5,62518,185May 20, 2025
Apr 1, 2025Kevin Chung
Chief Medical Officer
AGrant or award
Restricted Stock Unitderivative
+15,000$0.00$015,000Apr 3, 2025
Apr 1, 2025David A Green
Chief Financial Officer
AGrant or award
Restricted Stock Unitderivative
+15,000$0.00$015,000Apr 3, 2025
Nov 13, 2024Jennifer A Baird
director
AGrant or award
Restricted Stock Unitderivative
+8,000$0.00$08,000Dec 3, 2024
Nov 13, 2024Bernadette N Vincent
director
AGrant or award
Restricted Stock Unitderivative
+8,000$0.00$08,000Dec 3, 2024
Nov 18, 2024Kevin Chung
Chief Medical Officer
POpen-market purchase
Common Stock, par value $0.0001 per share
+4,250$1.99$8,45813,685Nov 19, 2024
Nov 15, 2024Eric Schlorff
Chief Executive Officer
AGrant or award
Restricted Stock Unitderivative
+65,000$0.00$065,000Nov 19, 2024
Nov 15, 2024Kevin Chung
Chief Medical Officer
AGrant or award
Restricted Stock Unitderivative
+15,000$0.00$015,000Nov 19, 2024
Nov 13, 2024Rick Barnett
director
AGrant or award
Restricted Stock Unitderivative
+4,000$0.00$04,000Nov 15, 2024
Nov 13, 2024Allan Collins
director
AGrant or award
Restricted Stock Unitderivative
+4,000$0.00$04,000Nov 15, 2024
Nov 13, 2024John Neuman
director
AGrant or award
Restricted Stock Unitderivative
+8,000$0.00$08,000Nov 15, 2024
Nov 13, 2024Kenneth Van Heel
director
AGrant or award
Restricted Stock Unitderivative
+4,000$0.00$04,000Nov 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ICU insider trading: SeaStar Medical Holding Corp | InsiderTell